Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
Atacand 4 mg tablets.
Pharmaceutical Form |
---|
Tablet. Round (diameter 7 mm), white tablets with a score and marked A/CF on one side and marked 004 on the other side. The tablet can be divided into equal doses. |
Each tablet contains 4 mg candesartan cilexetil.
Excipient with known effect: Each tablet contains 93.4 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Candesartan |
Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration. |
List of Excipients |
---|
Carmellose calcium |
PVC/PVDC blister packs of 7, 14, 28, 30, 56, 90 and 98 tablets.
HDPE bottles of 100 tablets.
Not all pack sizes may be marketed.
CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
PA2239/010/001
Date of first authorisation: 23 January 1998
Date of last renewal: 29 April 2007
Drug | Countries | |
---|---|---|
ATACAND | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.